I am a
Home I AM A Search Login

Papers of the Week

Papers: 30 Apr 2022 - 6 May 2022

2022 May 05

Pain Manag

Real-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey.


Pingree MJ, Hurdle M F, Spinner DA, Valimahomed A, Crosby ND, Boggs JW
Pain Manag. 2022 May 05.
PMID: 35510333.


This study presents real-world data from a cross-sectional follow-up survey of patients who previously received 60-day peripheral nerve stimulation (PNS) treatment for pain. A survey including validated pain and other related outcome measures was distributed to patients who previously underwent implantation of temporary PNS leads for 60-day PNS treatment. Among survey respondents who were at least 3 months from the start of treatment, most reported sustained clinically significant improvements in pain and/or quality of life, with the length of follow-up at the time of survey completion ranging from 3 to 30 months. These real-world data support recent prospective studies indicating that 60-day percutaneous PNS provides significant and sustained relief across a wide range of pain conditions.